Literature DB >> 15329361

Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis.

Ricardo M Santa-Rita1, Andréa Henriques-Pons, Helene S Barbosa, Solange L de Castro.   

Abstract

OBJECTIVES: Analysis of the effect of edelfosine, ilmofosine and miltefosine on Leishmania amazonensis and of potential targets of these lysophospholipid analogues.
METHODS: Quantification and ultrastructural analysis of the effect of lysophospholipid analogues on promastigote forms and on infected peritoneal macrophages, and flow cytometry analysis of treated promastigotes labelled with propidium iodide and rhodamine 123 (Rh123).
RESULTS: The lysophospholipid analogues presented potent antiproliferative activity with IC50/3 days of 1.9-3.4 microM for promastigotes and 4.2-9.0 microM for intracellular amastigotes. Treatment with these analogues in Schneider medium for 1 day led to a dose-dependent decrease in Rh123 fluorescence, an effect more accentuated in edelfosine-treated parasites, suggesting interference with the potential of the mitochondrial membrane. In both forms of L. amazonensis, edelfosine induced extensive mitochondrial damage, multinucleation and, in promastigotes, also led to plasma membrane alterations, formation of autophagic structures and membranous arrangements inside the flagellar pocket.
CONCLUSIONS: The alkylglycerophosphocholines edelfosine and ilmofosine were more active than the alkylphosphocholine miltefosine against promastigotes and intracellular amastigotes of L. amazonensis, and ultrastructural and flow cytometry data indicate the mitochondrion as a target of edelfosine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15329361     DOI: 10.1093/jac/dkh380

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  25 in total

1.  Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis.

Authors:  Marta Gontijo Aguiar; Aline Márcia Machado Pereira; Ana Paula Fernandes; Lucas Antonio Miranda Ferreira
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

2.  In vitro activity of perifosine: a novel alkylphospholipid against the promastigote stage of Leishmania species.

Authors:  María Gabriela Cabrera-Serra; Jacob Lorenzo-Morales; Marialina Romero; Basilio Valladares; José E Piñero
Journal:  Parasitol Res       Date:  2007-01-06       Impact factor: 2.289

3.  Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions.

Authors:  Susan Holbeck; Jianjun Chang; Anne M Best; Angie L Bookout; David J Mangelsdorf; Elisabeth D Martinez
Journal:  Mol Endocrinol       Date:  2010-04-07

4.  In vitro activity of the essential oil of Cymbopogon citratus and its major component (citral) on Leishmania amazonensis.

Authors:  Marta Regina Santin; Adriana Oliveira dos Santos; Celso Vataru Nakamura; Benedito Prado Dias Filho; Izabel Cristina Piloto Ferreira; Tânia Ueda-Nakamura
Journal:  Parasitol Res       Date:  2009-08-11       Impact factor: 2.289

5.  Ultrastructural analysis of edelfosine-treated trypomastigotes and amastigotes of Trypanosoma cruzi.

Authors:  R M Santa-Rita; H S Barbosa; S L de Castro
Journal:  Parasitol Res       Date:  2006-07-20       Impact factor: 2.289

6.  Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes.

Authors:  Juan Román Luque-Ortega; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

7.  Cellular effects of reversed amidines on Trypanosoma cruzi.

Authors:  C F Silva; M B Meuser; E M De Souza; M N L Meirelles; C E Stephens; P Som; D W Boykin; M N C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

8.  Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum.

Authors:  Paula S Lage; Miguel A Chávez-Fumagalli; Juliana T Mesquita; Laís M Mata; Simone O A Fernandes; Valbert N Cardoso; Manuel Soto; Carlos A P Tavares; João P V Leite; Andre G Tempone; Eduardo A F Coelho
Journal:  Parasitol Res       Date:  2015-09-07       Impact factor: 2.289

9.  Leishmania parasitophorous vacuole membranes display phosphoinositides that create conditions for continuous Akt activation and a target for miltefosine in Leishmania infections.

Authors:  Naixin Zhang; Samiksha Prasad; Charles-Eugene Huyghues Despointes; Jeffrey Young; Peter E Kima
Journal:  Cell Microbiol       Date:  2018-07-31       Impact factor: 3.715

10.  Efficacy of topical Miltefosine formulations in an experimental model of cutaneous leishmaniasis.

Authors:  Ma Florencia Peralta; Nadina A Usseglio; Ma Estefanía Bracamonte; Ma Laura Guzmán; Ma Eugenia Olivera; J Diego Marco; Paola A Barroso; Dolores C Carrer
Journal:  Drug Deliv Transl Res       Date:  2021-01-27       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.